Tech Center 1600 • Art Units: 1628 1629
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18851253 | COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF | Non-Final OA | Novartis AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy